Department of Cardiac Surgery, University of Leipzig Heart Center, Leipzig, Germany.
J Thorac Cardiovasc Surg. 2011 Feb;141(2):492-500, 500.e1. doi: 10.1016/j.jtcvs.2010.03.029. Epub 2010 May 5.
Mitochondrial dysfunction has been suggested as a potential cause for heart failure. Pressure overload is a common cause for heart failure. However, implementing pressure overload in mice is considered a model for compensated hypertrophy but not for heart failure. We assessed the suitability of minimally invasive transverse aortic constriction to induce heart failure in C57BL/6 mice and assessed mitochondrial biogenesis and function.
Minimally invasive transverse aortic constriction was performed through a ministernotomy without intubation (minimally invasive transverse aortic constriction, n = 68; sham operation, n = 43). Hypertrophy was assessed based on heart weight/body weight ratios and histologic analyses, and contractile function was assessed based on intracardiac Millar pressure measurements. Expression of selected metabolic genes was assessed with reverse transcription-polymerase chain reaction and Western blotting. Maximal respiratory capacity (state 3) of isolated mitochondria was measured with a Clark-type electrode.
Survival was 62%. Within 7 weeks, minimally invasive transverse aortic constriction induced significant hypertrophy (heart weight/body weight ratio: 10.08±0.28 mg/g for minimally invasive transverse aortic constriction vs 4.66±0.07 mg/g for sham operation; n=68; P<.01). Fifty-seven percent of mice undergoing minimally invasive transverse aortic constriction displayed signs of heart failure (pleural effusions, dyspnea, weight loss, and dp/dtmax of 3114±422 mm Hg/s, P<.05). All of them had heart weight/body weight ratios of greater than 10. Mice undergoing minimally invasive transverse aortic constriction with heart weight/body weight ratios of less than 10 had normal contractile function (dp/dtmax of 6471±292 mm Hg/s vs dp/dtmax of 6933±205 mmHg/s in sham mice) and no clinical signs of heart failure. The mitochondrial coactivator peroxisome proliferator-activated receptor γ coactivator alpha (PGC-1α) was downregulated in failing hearts only. PGC-1α and fatty acid oxidation gene expression were also decreased in failing hearts. State 3 respiration of isolated mitochondria was significantly reduced in all hearts subjected to pressure overload.
Contractile dysfunction and heart failure can be induced in wild-type mice by means of minimally invasive aortic constriction. Pressure overload-induced heart failure in mice is associated with mitochondrial dysfunction, as characterized by downregulation of PGC-1α and reduced oxidative capacity.
线粒体功能障碍被认为是心力衰竭的潜在原因。压力超负荷是心力衰竭的常见原因。然而,在小鼠中实施压力超负荷被认为是代偿性肥大的模型,而不是心力衰竭的模型。我们评估了微创横主动脉缩窄在 C57BL/6 小鼠中诱导心力衰竭的适用性,并评估了线粒体生物发生和功能。
通过无插管的小开胸术(微创横主动脉缩窄,n=68;假手术,n=43)进行微创横主动脉缩窄。基于心脏重量/体重比和组织学分析评估肥大,基于心内 Millar 压力测量评估收缩功能。通过逆转录-聚合酶链反应和 Western 印迹评估选定代谢基因的表达。使用 Clark 型电极测量分离线粒体的最大呼吸能力(状态 3)。
存活率为 62%。在 7 周内,微创横主动脉缩窄诱导明显的肥大(心脏重量/体重比:微创横主动脉缩窄为 10.08±0.28 mg/g,假手术为 4.66±0.07 mg/g;n=68;P<.01)。57%接受微创横主动脉缩窄的小鼠出现心力衰竭迹象(胸腔积液、呼吸困难、体重减轻和 dp/dtmax 为 3114±422 mm Hg/s,P<.05)。它们的心脏重量/体重比均大于 10。心脏重量/体重比小于 10 的微创横主动脉缩窄小鼠具有正常的收缩功能(dp/dtmax 为 6471±292 mm Hg/s,而假手术小鼠的 dp/dtmax 为 6933±205 mmHg/s)且无心力衰竭的临床迹象。只有衰竭的心脏中过氧化物酶体增殖物激活受体 γ 共激活因子 1α(PGC-1α)的线粒体共激活剂被下调。衰竭心脏中 PGC-1α 和脂肪酸氧化基因的表达也降低。所有承受压力超负荷的心脏的分离线粒体的状态 3 呼吸均显著降低。
通过微创主动脉缩窄可在野生型小鼠中诱导收缩功能障碍和心力衰竭。压力超负荷诱导的小鼠心力衰竭与线粒体功能障碍有关,其特征是 PGC-1α 下调和氧化能力降低。